(Q44363633)

2 December 2017

title

Design, synthesis and biological evaluation of benzimidazole/benzothiazole and benzoxazole derivatives as cyclooxygenase inhibitors (English)

1 reference

2 December 2017

Paramashivappa R

1

1 reference

2 December 2017

Phani Kumar P

series ordinal

2

1 reference

2 December 2017

Subba Rao PV

series ordinal

3

1 reference

2 December 2017

Srinivasa Rao A

series ordinal

4

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

Bioorganic & Medicinal Chemistry Letters

2 December 2017

published in

1 reference

2 December 2017

volume

13

1 reference

2 December 2017

issue

4

1 reference

2 December 2017

page(s)

657-660

1 reference

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2901006-5

7 January 2021

Aspirin selectively inhibits prostaglandin production in human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2901006-5

7 January 2021

Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2901006-5

7 January 2021

Human cyclooxygenase-2 cDNA

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2901006-5

7 January 2021

Prostaglandin endoperoxide H synthases-1 and -2.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2901006-5

7 January 2021

Prostaglandin synthase 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2901006-5

7 January 2021

Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2901006-5

7 January 2021

Inhibition of lipoxygenase and prostaglandin endoperoxide synthase by anacardic acids.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2901006-5

7 January 2021

Tyrosinase inhibitors from Anacardium occidentale fruits

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2901006-5

7 January 2021

Analogues of poison ivy urushiol. Synthesis and biological activity of disubstituted n-alkylbenzenes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2901006-5

7 January 2021

Novel method for isolation of major phenolic constituents from cashew (Anacardium occidentale L.) nut shell liquid

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2901006-5

7 January 2021

Synthesis and evaluation of a new class of nifedipine analogs with T-type calcium channel blocking activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2901006-5

7 January 2021

Cox-2 inhibitory effects of naturally occurring and modified fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2901006-5

7 January 2021

Novel dual inhibitors of 5-lipoxygenase and thromboxane A2 synthetase: synthesis and structure-activity relationships of 3-pyridylmethyl-substituted 2-amino-6-hydroxybenzothiazole derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2901006-5

7 January 2021

(H+, K+)-ATPase inhibiting 2-[(2-pyridylmethyl)sulfinyl]benzimidazoles. 4. A novel series of dimethoxypyridyl-substituted inhibitors with enhanced selectivity. The selection of pantoprazole as a clinical candidate

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2901006-5

7 January 2021

Synthesis and biological evaluation of 3,4-diaryloxazolones: A new class of orally active cyclooxygenase-2 inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2901006-5

7 January 2021

10.1016/S0960-894X(02)01006-5

Identifiers

DOI

1 reference

2 December 2017

1 reference